2021
DOI: 10.1016/j.biopha.2021.111273
|View full text |Cite
|
Sign up to set email alerts
|

Diabetes and hypertension: Pivotal involvement of purinergic signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(30 citation statements)
references
References 260 publications
1
29
0
Order By: Relevance
“…A robust body of evidence supports the involvement of purinergic signaling in several disease conditions, such as cancer [ 17 , 22 28 ], inflammatory process [ 29 ], diabetes, and hypertension [ 30 , 31 ]. Recently, studies have hypothesized the potential role of purinergic signaling in COVID-19 [ 32 35 ].…”
Section: Introductionmentioning
confidence: 99%
“…A robust body of evidence supports the involvement of purinergic signaling in several disease conditions, such as cancer [ 17 , 22 28 ], inflammatory process [ 29 ], diabetes, and hypertension [ 30 , 31 ]. Recently, studies have hypothesized the potential role of purinergic signaling in COVID-19 [ 32 35 ].…”
Section: Introductionmentioning
confidence: 99%
“…As stated before Akt, a major component, plays a key role in the insulin-regulated GLUT4 trafficking. Decreased expression of Akt leads to decline in the expression of GLUT4 (Glucose transporter) in skeletal muscle of type-2 diabetic rats [ 26 ]. β-Caryophyllene treatment significantly enhanced the gene ( Figure 2B ) and protein ( Figure 3B ) expression of GLUT 4 as a result of increased Akt activation in skeletal muscle, which in turn significantly increased the glucose uptake, and oxidation in skeletal muscle of type-2 diabetic rats.…”
Section: Resultsmentioning
confidence: 99%
“…Purinergic signalling involves multiple receptors and extracellular enzymes that provides a system of cell-cell communication through the recognition and degradation of extracellular nucleotides and adenosine. An increasing number of studies have placed the purinergic system as a key player in numerous physiopathological conditions, including those involved in the in ammatory response such as T2DM 34 . Moreover, our data show signi cant activation of renin-angiotensin signalling at 4 h post HG treatment, however not in NG conditions.…”
Section: Discussionmentioning
confidence: 99%